Lv64
2390 积分 2022-01-27 加入
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up
3天前
已完结
Effects of CD19 CAR T Cell Therapy on Quality of Life and Direct Healthcare Costs in Systemic Lupus Erythematosus: A Preliminary Analysis
3天前
求助中
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis
3天前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
3天前
已完结
Safety of CAR T-Cell Therapy in Patients with Active Autoimmune Diseases: A Case Report (P3-14.003)
3天前
待确认
CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching study
3天前
已完结
CAR T cells induce remission in a patient with refractory SLE
3天前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
3天前
已完结
Relapse after anti-CD19 CAR T-cell therapy in a patient with severe rheumatoid arthritis and multiple sclerosis effectively treated by autologous stem cell transplantation
7天前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
8天前
已完结
皖公网安备34019202002308
